TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20615859

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 33
Study: 19103535

Group type: EXPERIMENTAL
Intervention: 20 mg atorvastatin every other day
Number of subjects: 61

Group type: COMPARATOR
Intervention: 20 mg atorvastatin daily
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 61
Study: 15829861

Group type: EXPERIMENTAL
Intervention: Progressive addition lenses (PALs)
Number of subjects: 469

Group type: COMPARATOR
Intervention: Single-vision lenses (SVLs)
Number of subjects: 469
Study: 12028506

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 537
Study: 10452673

Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg twice a day (H2RA)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily (PPI)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: H. pylori (+) patients with Famotidine
Number of subjects: 71

Group type: COMPARATOR
Intervention: H. pylori (+) patients with Omeprazole
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Daily drinkers
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Social drinkers
Number of subjects: 71
Study: 8520639

Group type: EXPERIMENTAL
Intervention: Air filled balloon (n = 11)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham procedure (n = 9)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 2201825

Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive timed sequential treatment using high dose cytarabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized trials
Number of subjects: 0
Study: 334638

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 31145382

Group type: EXPERIMENTAL
Intervention: Resisted band squat
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Weighted countermovement jumps
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Drop jumps from a 45-cm box
Number of subjects: 11

Group type: COMPARATOR
Intervention: Swim-specific control
Number of subjects: 11
Study: 31774468

Group type: EXPERIMENTAL
Intervention: Repeat hepatectomy
Number of subjects: 240

Group type: COMPARATOR
Intervention: PRFA
Number of subjects: 240
Study: 31324358

Group type: EXPERIMENTAL
Intervention: High-dose dipyridamole stress echocardiography (0.84 mg/kg)
Number of subjects: 3059
Study: 28118659

Group type: EXPERIMENTAL
Intervention: Video laryngoscopy
Number of subjects: 371

Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 371
Study: 25855466

Group type: EXPERIMENTAL
Intervention: Passive maxillary plates (IO+) during the first year of life
Number of subjects: 54

Group type: COMPARATOR
Intervention: No passive maxillary plates (IO-) during the first year of life
Number of subjects: 54
Study: 23486302

Group type: EXPERIMENTAL
Intervention: Whole-body vibration therapy (WBV) with exercise training for 15 minutes, 3 days per week for 8 weeks
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (exercise without WBV)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Whole-body vibration therapy (WBV) with exercise training
Number of subjects: 82
Study: 21658558

Group type: EXPERIMENTAL
Intervention: SYNTAX score tertile <7 (n = 854)
Number of subjects: 2627

Group type: EXPERIMENTAL
Intervention: SYNTAX score tertile ≥ 7 and <13 (n = 825)
Number of subjects: 2627

Group type: EXPERIMENTAL
Intervention: SYNTAX score tertile ≥ 13 (n = 948)
Number of subjects: 2627
Study: 19454777

Group type: EXPERIMENTAL
Intervention: Standing on the dominant leg (UNID)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Standing on the nondominant leg (UNIND)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bipedal stance
Number of subjects: 10
Study: 16676791

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Supplemental Oxygen at 3 L per minute
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo-CPAP
Number of subjects: 76
Study: 14579160

Group type: EXPERIMENTAL
Intervention: Transforaminal corticosteroid injection
Number of subjects: 31

Group type: COMPARATOR
Intervention: Interspinous corticosteroid injection
Number of subjects: 31
Study: 10627112

Group type: EXPERIMENTAL
Intervention: Alcohol expectancy variables
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Co-participant drinking
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sexual arousal
Number of subjects: 100
Study: 9132089

Group type: EXPERIMENTAL
Intervention: Helical contrast-enhanced CT
Number of subjects: 53

Group type: COMPARATOR
Intervention: Gradient-echo MR
Number of subjects: 53

Group type: COMPARATOR
Intervention: Vascular MR experts
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Enhanced CT experts
Number of subjects: 53
Study: 1381218

Group type: EXPERIMENTAL
Intervention: recombinant consensus interferon (rIFN-con-1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: recombinant interferon-alpha-2b (r-IFN-alpha-2b)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 10
Study: 6208742

Group type: EXPERIMENTAL
Intervention: Hypotensive anesthesia with HDHE
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hypotensive anesthesia with dextran 70
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Normotensive anesthesia with HDHE
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Normotensive anesthesia with dextran 70
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Thromboprophylaxis with HDHE
Number of subjects: 120

Group type: COMPARATOR
Intervention: Thromboprophylaxis with dextran 70
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 31239114

Group type: EXPERIMENTAL
Intervention: Multimodal physical exercise program (1-hour sessions, moderate intensity, twice a week for 12 weeks)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (CG; no intervention)
Number of subjects: 56
Study: 29090526

Group type: EXPERIMENTAL
Intervention: Capecitabine with radiation therapy (RT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Historical control (not specified treatment)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Capecitabine with RT
Number of subjects: 44
Study: 27636922

Group type: EXPERIMENTAL
Intervention: Decimeter wave therapy and halotherapy in addition to basic drug treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Basic drug therapy
Number of subjects: 36
Study: 25340337

Group type: EXPERIMENTAL
Intervention: Home visiting intervention by community health workers (CHWs) trained in cognitive-behavioral strategies, in addition to clinic care.
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Home visiting intervention among women living with HIV.
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Number of home visits received.
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Control group receiving healthcare at clinics.
Number of subjects: 1238
Study: 23145504

Group type: EXPERIMENTAL
Intervention: Singing classes
Number of subjects: 24

Group type: COMPARATOR
Intervention: Film club
Number of subjects: 24
Study: 20701902

Group type: EXPERIMENTAL
Intervention: Controlled tubular compression stocking
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional compression bandage for one week
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional compression bandage replaced by controlled tubular compression stocking at 5h
Number of subjects: 55
Study: 17950857

Group type: EXPERIMENTAL
Intervention: 25 mg pitrakinra (subcutaneous injection once daily)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (subcutaneous injection once daily)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: 60 mg pitrakinra (nebulisation twice daily)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (nebulisation twice daily)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of pitrakinra
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Inhalation of pitrakinra
Number of subjects: 56
Study: 16258094

Group type: EXPERIMENTAL
Intervention: Risk-adapted alternating short-course multiagent systemic and intrathecal chemotherapy, cranial irradiation if indicated, and conventional maintenance therapy.
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Risk-adapted treatment for group A (early BM relapse).
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Risk-adapted treatment for group B (late BM relapse).
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Risk-adapted treatment for group C (isolated extramedullary relapse).
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Risk-adapted treatment with individual regimens for 24 patients with exceptionally poor prognosis.
Number of subjects: 183
Study: 12079437

Group type: EXPERIMENTAL
Intervention: NCEP step I diet with supervised aerobic exercise program
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: NCEP step II diet with supervised aerobic exercise program
Number of subjects: 41

Group type: COMPARATOR
Intervention: NCEP step I diet with regular exercise (standard lifestyle recommendations)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: NCEP step II diet without supervised aerobic exercise program
Number of subjects: 41
Study: 9515848

Group type: EXPERIMENTAL
Intervention: Conventional nCPAP
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Self-adjusting nCPAP
Number of subjects: 50
Study: 8062153

Group type: EXPERIMENTAL
Intervention: Ipriflavone (IP) 600 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 40
Study: 3178248

Group type: EXPERIMENTAL
Intervention: Prednisolone plus ten large-volume plasma exchanges over four weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prednisolone alone
Number of subjects: 40
Study: 4758424

Group type: EXPERIMENTAL
Intervention: Lanoxin tablets produced between 1969 and 1972 (1.5 mg dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recently produced Lanoxin tablets (1.5 mg dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recent independently produced batches of Lanoxin tablets (0.5 mg dose)
Number of subjects: 0
Study: 31939326

Group type: EXPERIMENTAL
Intervention: Fast-track surgery combined with a clinical nursing pathway
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine nursing during the perioperative period
Number of subjects: 70
Study: 31270732

Group type: EXPERIMENTAL
Intervention: eCoFit smartphone application and integrated group sessions (weeks 1-10)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: eCoFit smartphone application only (weeks 11-20)
Number of subjects: 84
Study: 28120630

Group type: EXPERIMENTAL
Intervention: Ropinirole PR 16 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ropinirole PR 8 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ropinirole PR (all doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25641537

Group type: EXPERIMENTAL
Intervention: Low-sodium diet (1500 mg/d)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Moderate-sodium diet (2300 mg/d)
Number of subjects: 38
Study: 24154787

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Prasugrel 60 mg
Number of subjects: 100
Study: 22707609

Group type: EXPERIMENTAL
Intervention: Belimumab 1 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Belimumab 10 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19450919

Group type: EXPERIMENTAL
Intervention: 17-betaestradiol 0.01%
Number of subjects: 36

Group type: COMPARATOR
Intervention: Isoflavones 40% (genistein 4%)
Number of subjects: 36
Study: 17968793

Group type: EXPERIMENTAL
Intervention: Type 2 distal fibular physis position
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Type 3 distal fibular physis position
Number of subjects: 30

Group type: COMPARATOR
Intervention: Type 1 distal fibular physis position
Number of subjects: 30
Study: 15633711

Group type: EXPERIMENTAL
Intervention: Low-dose anti-snake venom (6 vials)
Number of subjects: 100

Group type: COMPARATOR
Intervention: High-dose anti-snake venom (12 vials)
Number of subjects: 100
Study: 11502921

Group type: EXPERIMENTAL
Intervention: Lamotrigine (titrated from 25 to 400 mg/day)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 59

Group type: COMPARATOR
Intervention: Lamotrigine and Placebo
Number of subjects: 59
Study: 9013103

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 28
Study: 7930196

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 76

Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 76
Study: 3355738

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 0.01 mg kg‐1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Atropine 0.02 mg kg‐1
Number of subjects: 40
Study: 2334627

Group type: EXPERIMENTAL
Intervention: 0.3‐molar sodium citrate 15 ml (sodium citrate 1.16 g)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: effervescent cimetidine‐sodium citrate combination (cimetidine 400 mg with sodium citrate 0.9 g)
Number of subjects: 147

Group type: COMPARATOR
Intervention: no premedication
Number of subjects: 147
Study: 1094842

Group type: EXPERIMENTAL
Intervention: 20 mg of methylphenidate daily
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: methylphenidate alone
Number of subjects: 8

Group type: COMPARATOR
Intervention: 160 mg of caffeine
Number of subjects: 8

Group type: COMPARATOR
Intervention: decaffeinated coffee
Number of subjects: 8

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 8
Study: 31495254

Group type: EXPERIMENTAL
Intervention: Reproductive life plan counseling (RLPC)
Number of subjects: 1946

Group type: COMPARATOR
Intervention: Standard contraceptive counseling
Number of subjects: 1946
Study: 28879243

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) resource
Number of subjects: 56
Study: 25701265

Group type: EXPERIMENTAL
Intervention: Exercise and nicotine lozenge
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nicotine lozenge alone
Number of subjects: 30
Study: 23586977

Group type: EXPERIMENTAL
Intervention: Er:YAG laser short pulse (SP)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Er:YAG laser super short pulse (SSP)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: sandblasted
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: sandblasted+SP
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: sandblasted+SSP
Number of subjects: 150

Group type: COMPARATOR
Intervention: Transbond XT (control group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: RelyX U 200
Number of subjects: 150
Study: 21269578

Group type: EXPERIMENTAL
Intervention: Second TNF-alpha inhibitor
Number of subjects: 4441
Study: 19713451

Group type: EXPERIMENTAL
Intervention: Exogenous natural porcine surfactant HL 10
Number of subjects: 418

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 418
Study: 17429084

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus supportive care
Number of subjects: 85

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 85
Study: 16042672

Group type: EXPERIMENTAL
Intervention: Pharmacist-led pharmaceutical care programme
Number of subjects: 208

Group type: COMPARATOR
Intervention: Traditional services
Number of subjects: 208
Study: 11124747

Group type: EXPERIMENTAL
Intervention: High-procyanidin chocolate (4.0 mg/g)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: In vitro procyanidin treatment
Number of subjects: 10
Study: 9609623

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/day
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.8 mg/day
Number of subjects: 756

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 756
Study: 7840686

Group type: EXPERIMENTAL
Intervention: Lactate dehydrogenase (LDH)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Hydroxybutyrate dehydrogenase (HBDH)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (normal controls)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Asymptomatic carrier group
Number of subjects: 3
Study: 3122698

Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride
Number of subjects: 11
Study: 28853196

Group type: EXPERIMENTAL
Intervention: LSSM arm (n=274)
Number of subjects: 548

Group type: COMPARATOR
Intervention: Conventional arm (n=274)
Number of subjects: 548
Study: 27810187

Group type: EXPERIMENTAL
Intervention: Sodium Oxybate (SXB)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Sodium Oxybate (SXB) + Modafinil
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 22834968

Group type: EXPERIMENTAL
Intervention: Adalimumab 80 mg followed by 40 mg every other week for 7 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 22559856

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Intravenous morphine (0.1 mg/kg)
Number of subjects: 240
Study: 19959611

Group type: EXPERIMENTAL
Intervention: Interdental brush with a short curved handle and triangular cross-section (IDB)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Monotufted brush head (MTB)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Interdental brush (IDB)
Number of subjects: 110
Study: 17666252

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency volumetric tissue reduction (RFVTR) using Coblator II ENT
Number of subjects: 150

Group type: COMPARATOR
Intervention: Monopolar radiofrequency volumetric tissue reduction (RFVTR) using Somnoplasty
Number of subjects: 150
Study: 16199715

Group type: EXPERIMENTAL
Intervention: Selective head cooling (SHC)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Whole-body cooling (WBC)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Noncooled infants
Number of subjects: 86
Study: 11862974

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis solution containing amino acids and bicarbonate
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis solution containing glucose and bicarbonate
Number of subjects: 11

Group type: COMPARATOR
Intervention: Peritoneal dialysis solution containing glucose and lactate
Number of subjects: 11
Study: 10556990

Group type: EXPERIMENTAL
Intervention: MUFA diet (40 E% fat, 25 E% as MUFA, 45 E% carbohydrate, 15 E% protein)
Number of subjects: 16

Group type: COMPARATOR
Intervention: CHO diet (55 E% carbohydrate, 30 E% fat, 15 E% protein)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both diets (MUFA and CHO)
Number of subjects: 16
Study: 8753945

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 26

Group type: COMPARATOR
Intervention: None (Control)
Number of subjects: 26
Study: 1861487

Group type: EXPERIMENTAL
Intervention: Phase I exercise therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ward activities and ad libitum walking (Control)
Number of subjects: 30
Study: 6401392

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional oral nutrition (Control)
Number of subjects: 27
Study: 31689513

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) as an adjunct to full-mouth scaling (FMS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Full-mouth scaling (FMS) alone
Number of subjects: 50
Study: 28067467

Group type: EXPERIMENTAL
Intervention: Image guidance using CMUD (Sonic Window©) for 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard cannulation (control group) for 3 weeks
Number of subjects: 0
Study: 26493094

Group type: EXPERIMENTAL
Intervention: Letrozole (adjuvant therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen (adjuvant therapy)
Number of subjects: 0
Study: 24912399

Group type: COMPARATOR
Intervention: Conventional group (2-adhesive retainer design)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Mixed group (combining adhesive retainer with a crown or partial crown)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Mixed group
Number of subjects: 84
Study: 22335305

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX) applied for 60 seconds on acid-etched dentin in ARC/CHX group
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 24% ethylenediamine tetra‐acetic acid gel (EDTA) applied for 45 seconds on smear-covered dentin in U100/EDTA group
Number of subjects: 10

Group type: COMPARATOR
Intervention: No pretreatment (control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: RelyX ARC (ARC)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: RelyX U100 (U100)
Number of subjects: 10
Study: 20699022

Group type: EXPERIMENTAL
Intervention: Electronic reminder for further diagnostics of Lynch syndrome
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 17629926

Group type: EXPERIMENTAL
Intervention: Echocardiography (US) using Teichholz's M-mode formula
Number of subjects: 135

Group type: COMPARATOR
Intervention: Cardiac Magnetic Resonance (CMR) imaging
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Echocardiography (US)
Number of subjects: 135
Study: 15738748

Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLU)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 62
Study: 12196418

Group type: EXPERIMENTAL
Intervention: AHA step 2 diet plus endurance exercise (1 hour, three times a week)
Number of subjects: 64

Group type: COMPARATOR
Intervention: AHA step 1 diet plus stretching exercise (control group)
Number of subjects: 64
Study: 10442214

Group type: EXPERIMENTAL
Intervention: Topical evening primrose oil in a stable water-in-oil emulsion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Topical evening primrose oil in an amphiphilic emulsion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle control (amphiphilic emulsion)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle control (stable water-in-oil emulsion)
Number of subjects: 20
Study: 7570970

Group type: EXPERIMENTAL
Intervention: Sandimmun Neoral
Number of subjects: 57

Group type: COMPARATOR
Intervention: Regular Sandimmun
Number of subjects: 57